+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2014-05-28Number of Pages: 103

Medical Imaging Reagents Market (Class: Contrast Reagents, Optical Reagents and Nuclear Reagents; Technology: Nanoparticles, Fluorescent Proteins, Fluorescent Dyes and Probes, Radiopharmaceuticals and Quantum Dots & Application: Diagnostics, Drug Discovery and Development and Research and Development) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Medical imaging reagents play an important role in diagnostic, pharmaceuticals, biotechnology medical and life science industries. Medical imaging reagents allow clinicians and healthcare providers to determine whether a tumor is malignant or benign and enables to locate any metastatic cancerous sites in the body. Medical imaging reagents are chemicals that are specially designed to enhance images produced through imaging systems. Ongoing advances in proteomics, genomics and cellular analysis are supported by sophisticated imaging technologies including nanoparticles, radiopharmaceuticals, fluorescent proteins, quantum dots and fluorescent dyes and probes. Development in technologies such as polymerase chain reaction (PCR), biochips, hybrid imaging modalities and DNA sequencing relies on sensitive medical imaging reagents for producing enhanced images with detailed information. 

The primary factors driving the growth of the medical imaging reagents market are increasing demand for diagnostic and functional imaging technologies. Moreover, other factors contributing to the growth of this market are escalating incidence rate of cardiac disorders and cancer. Furthermore, immense application scope of advance medical imaging reagents and patient safety are also some of the factors driving the growth of the medical imaging reagents market. However, some of the important factors that negatively affect the growth of this market are shortage in supplies; high development cost coupled with unfavorable reimbursement policies and low awareness rate among the patient population.

The medical imaging reagents market is categorized on the basis of class, technology and applications. The three main classes of imaging reagents are contrast reagents, optical reagents and nuclear reagents. The contrast reagents market of the medical imaging reagents accounted for the largest market in 2011 (44%). However, the nuclear reagents market is expected to experience the fastest growth rate during the forecast period owing to the high adoption rate for localized tracers and nuclear medicine. Moreover, the technology segment comprises nanoparticles, fluorescent proteins, radiopharmaceuticals, quantum dots, fluorescent dyes and probes. Among these, nanoparticles technology is expected to grow at a high growth rate of over 8% from 2013 to 2019 due to the widespread applicability of these technologies along with high research and development initiatives being taken up for the development of their application areas. Furthermore, in terms of applications, this market is categorized into diagnostics, drug discovery and development as well as research and development; among which, drug discovery and development is expected to witness the highest growth during the forecast period. This growth can be attributed to the growing adoption rate of medical imaging reagents in the pre-clinical studies and medical interventions. However, diagnostic applications accounted for the largest market in terms of revenue due to the escalating patient base of chronic diseases (e.g. cancer, cardiovascular and neurological diseases).

North America is the largest market for medical imaging reagents owing to the increased incidence of cancer, cardiovascular and neurological diseases as well as high awareness about advanced imaging modalities and reagents, followed by Europe. However, rise in healthcare expenditure and the prevailing unstable economic conditions have led to a sluggish growth in the global medical imaging reagents market. Asia-Pacific is expected to foresee the highest growth due to strong economic developments, high incidence rate of cardiovascular diseases coupled with increasing demand for non-ionizing imaging reagents.

Bayer Healthcare AG, Becton Dickinson & Company, Bracco Imaging SpA, Cardinal Health, Inc., GE Healthcare, Lantheus Medical Imaging, Inc., Mallinckrodt Pharmaceuticals and Thermo Fisher Scientific, Inc. are major companies leading the medical imaging reagents market.

medical-imaging-reagents-market


Medical imaging reagents are an inextricable part of industries such as biotechnology, diagnostics, pharmaceuticals, and life sciences. The report on medical imaging reagents analyzes the market using a four pronged approach: Class, technology type, application, and geographical region. The report analyzes the market for each segment based on its past, current and forecasted revenues (USD million). The report also estimates the percentage of the compounded annual growth rate (CAGR) for each of these segments for the period 2013 to 2019, with 2012 being the base year. 

Besides critical market indicators and trends, the report also offers a deeper understanding of the prevailing and forecasted market dynamics, which include: drivers, restraints, trends, and opportunities. The report’s market overview section focuses on a qualitative analysis of the medical imaging reagents market. This section also carries an evaluation of the bargaining power of buyers and suppliers as well as threat from alternatives and new entrants using the Porter’s five forces analysis model.

Overview of the Medical Imaging Reagents Market

The global medical imaging reagents market has received an impetus from a rise in the incidence of cardiovascular diseases and cancer. Medical imaging reagents are unique chemical compounds in that they help diagnosticians and medical care providers determine the malignancy or benignancy of a tumor. Reagents have been found to be a fairly reliable method of establishing the presence of metastatic cancer in a patient. The presence of reagents during medical imaging helps better identify suspicious growths and tumors in the body.

This report segments the imaging reagents market based on three aspects: Class, applications, technology type, and geographical region. Based on products, the market has been segmented into the following types of reagents: Contrast, optical and nuclear reagents. On the basis of technology, the segments analyzed in the report include: Nanoparticles, radiopharmaceuticals, fluorescent proteins, fluorescent dyes, quantum dots, and probes. 

Similarly, on the basis of applications, the medical imaging reagents market has been split into three distinct segments: Diagnostics, research and development, and drug discovery and development. 

In recent years, the use of technologies such as biochips, polymerase chain reaction (PCR), DNA sequencing, and hybrid imaging modalities has caught on. All of these technologies rely on medical imaging reagents that are highly sensitive, so as to produce enhanced images. As a result, the growth of the medical imaging reagents market will be directly proportional to the deployment of innovative technologies in healthcare and diagnostic technologies market.

The most influential drivers in the medical imaging reagents market are: A palpable increase in the demand for functional imaging and diagnostic technologies, the sheer compatibility of reagents in various applications and an increased emphasis on patient safety. On the other hand, a short supply of materials and high development cost of reagents could adversely impact the market in the coming years. To counter the impact of these market restraints, companies could focus on opportunities such as development of nuclear products for personalized therapies.

Companies Mentioned in the Medical Imaging Reagents Market Report

The Company Profiles section of this report analyzes players such as: Bayer Healthcare AG, GE Healthcare, Bracco Imaging SpA, Lantheus Medical Imaging, Inc., Siemens Healthcare, Mallinckrodt Pharmaceuticals, and Thermo Fisher Scientific, Inc. 

Global Medical Imaging Reagents Market Segmentation, by Class
  • Contrast reagents
  • Optical reagents
  • Nuclear reagents
Global Medical Imaging Reagents Market Segmentation, by Technology
  • Nanoparticles
  • Fluorescent proteins
  • Radiopharmaceuticals
  • Quantum dots
Global Medical Imaging Reagents Market Segmentation, by Application
  • Diagnostics
  • Drug discovery and development
  • Research and development
Global Medical Imaging Reagents Market Segmentation, by Geography
  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW)
This report gives you access to decisive data such as:
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for the coming years 
Key highlights of this report
  • Overview of key market forces propelling and restraining market growth 
  • Up-to-date analyses of market trends and technological improvements 
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors 
  • An array of graphics and SWOT analysis of major industry segments 
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis 
  • Offers a clear understanding of the competitive landscape and key product segments


 
 
Back To Top